Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-04-30 to 2024-04-30
Current total value of award: $1037.6
Description: 4564445542!HYDROXYZINE HCL INJ